ONdrugDelivery - ONdrugDelivery - drug delivery industry specialised b2b information

#136_2022_Aug_Nemera_Featured

INDUSTRIALISATION

HOLISTIC DEVELOPMENT & INDUSTRIALISATION OF DRUG DELIVERY DEVICES

Mark Tunkel and Niyati Sapatnekar discuss Nemera’s holistic approach to development and industrialisation.

INDUSTRIALISATION

EMBRACING OPPORTUNITIES PRESENTED BY DIGITALISATION: USING DATA TO DRIVE PERFORMANCE

Otto Abildgaard and Sebastian Berninger-Lund review the four-stage process Stevanato has developed to bring improvements in time to market through optimised manufacturing.

#136_2022_Aug_SHL_Featured4

INDUSTRIALISATION

CONTINUOUS IMPROVEMENT: FROM ABSTRACTION TO REALITY

Tracy Pedreso discusses SHL Medical’s strategy for making continuous improvement a reality.

IMPROVE YOUR BIOPHARMACEUTICAL WORKFLOW: 6 BENEFITS OF SINGLE-USE SYSTEM TECHNOLOGIES

IMPROVE YOUR BIOPHARMACEUTICAL WORKFLOW: 6 BENEFITS OF SINGLE-USE SYSTEM TECHNOLOGIES

Sara Dorman discusses the benefits of single-use systems, including how they help accelerate a drug product’s journey to market securely and more sustainably.

FROM SIMULATION TO SPRING SATISFACTION

INDUSTRIALISATION

Drew Jelgerhuis

Scherdel Medtec North America

FROM SIMULATION TO SPRING SATISFACTION

Drew Jelgerhuis discusses the power of simulation to enhance a drug delivery device design project, including faster development times and reduced costs.

INDUSTRIALISATION OF PHARMACEUTICAL AND MEDICAL DEVICES IN THE SCIENTIFIC MOULDING APPROACH

INDUSTRIALISATION

INDUSTRIALISATION OF PHARMACEUTICAL AND MEDICAL DEVICES IN THE SCIENTIFIC MOULDING APPROACH

Thomas Rudolph, Markus Reil, Stefan Schumann and Tobias Weigert discuss Gerresheimer’s strategy for managing potential risks across the entire product lifecycle.

INTERVIEW: RENAN JOEL, CONNECT IN PHARMA CONFERENCE

INTERVIEW: RENAN JOEL, CONNECT IN PHARMA CONFERENCE

Renan Joel, Easyfairs' Divisional Director Packaging – UK, France, Italy & Switzerland, talks with ONdrugDelivery about the upcoming inaugural Connect in Pharma conference in Geneva.

INDUSTRIALISATION AND SCALE-UP OF DRUG DELIVERY DEVICES

INDUSTRIALISATION

Dr Barry McDermott

West Pharmaceutical Services

INDUSTRIALISATION AND SCALE-UP OF DRUG DELIVERY DEVICES

Barry McDermott and Shari Krusniak look at the manufacturing processes involved in bringing a new drug delivery system and formulation to market.

INTERVIEW: Piyush Agarwal, Tjoapack

INTERVIEW: Piyush Agarwal, Tjoapack

Piyush Agarwal talks with ONdrugDelivery about the current state of the injectable pharmaceuticals market and how working with a specialist contract packaging organisation can help pharma companies navigate their product through this rapidly evolving sector and deliver their product to market on time.

SINGLE USE SYSTEMS – THE FUTURE OF BIOPHARMACEUTICAL PROCESSING

SINGLE USE SYSTEMS – THE FUTURE OF BIOPHARMACEUTICAL PROCESSING

Jeff Lowe considers single-use systems and looks at their role in the future of biopharmaceutical processing.

DISSECTING THE DELICATE DELIVERY PROCESS FOR OCULAR GENE THERAPY

Dr Yongdong Zhou

DISSECTING THE DELICATE DELIVERY PROCESS FOR OCULAR GENE THERAPY

Yongdong Zhou considers the challenges of ocular gene therapy delivery approaches.

NEXT-GENERATION CAPSULE FILLING: MG2 AND THE DM² PROJECT

INDUSTRIALISATION

NEXT-GENERATION CAPSULE FILLING: MG2 AND THE DM² PROJECT

MG2 introduces the UK Made Smarter Innovation - Digital Medicine Manufacturing (DM²) Research Centre, which it has recently joined as an industrial partner, and describes how it will develop an AI-driven microscale capsule filling system for the selection of formulation and process parameters.

ROUNDTABLE: TRENDS AND INNOVATIONS IN ORAL DRUG DELIVERY

ROUNDTABLE: TRENDS AND INNOVATIONS IN ORAL DRUG DELIVERY

Michael Morgen of Lonza Bend, Torkel Gren of Recipharm, and Yogesh Sadhale of Metrics Contract Services, discuss the current trends and innovations influencing oral drug delivery development and what their respective companies can offer to pharma in this space.

INFLUENCE OF ADDITIVES ON THE ELECTROSTATIC CHARGE BUILD-UP OF EXCIPIENTS

Dr Aurelien Neveu

INFLUENCE OF ADDITIVES ON THE ELECTROSTATIC CHARGE BUILD-UP OF EXCIPIENTS

Aurélien Neveu, Devang Patel and Filip Francqui present a study investigating the influence of additives on the tribocharging behaviour of two excipients using Granutools’ GranuCharge instrument.

Video: Introducing Connect in Pharma

Video: Introducing Connect in Pharma

This video introduces Connect in Pharma, the new annual event dedicated to advanced pharmaceuticals downstream from the molecule and biotechnology, designed to drive innovation, business and new partnerships in four key areas: innovative packaging; drug delivery systems; CMO/CDMO; and filling and assembly.

MEETING AN UNMET PHARMA NEED: PIONEERING THE WAY TO A CONNECTED FUTURE

Chelsea Williams

MEETING AN UNMET PHARMA NEED: PIONEERING THE WAY TO A CONNECTED FUTURE

Chelsea Williams, Nagisa Kobashi and Nils Weber discuss the digital transformation of injectables, where drug formulation and device are enmeshed within a connected ecosystem powered by patient data.

A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED CLINICAL TRIALS – THE HUMAN FACTORS RESULTS ARE IN!

BD (Becton Dickinson & Company)

A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED CLINICAL TRIALS – THE HUMAN FACTORS RESULTS ARE IN!

Aurélie Pager and Mircea Despa follow up on an article published in the December 2021 issue of ONdrugDelivery. BD has now completed a human factors study assessing the usability, acceptance and ease of use of its connected injection prototype for clinical trials.

PAVING THE WAY TO INTEGRATED DEVICE-DIGITAL SOLUTIONS

Dr Andreas Schneider

PAVING THE WAY TO INTEGRATED DEVICE-DIGITAL SOLUTIONS

Andreas Schneider and Philippe Müller discuss the potential benefits and challenges of implementing connected device-digital solutions within the healthcare sector to improve the treatment of chronic conditions.

FOCUS ON ADHERENCE TO EMBRACE DCT BENEFITS

Dr Bernard Vrijens

FOCUS ON ADHERENCE TO EMBRACE DCT BENEFITS

Bernard Vrijens looks at the effect of decentralised clinical trials on medication adherence in clinical studies.

CONNECTING PATIENTS AND HEALTHCARE PROVIDERS IN THE AGE OF SELF-ADMINISTERED INJECTABLE DRUGS

Bespak by Recipharm

CONNECTING PATIENTS AND HEALTHCARE PROVIDERS IN THE AGE OF SELF-ADMINISTERED INJECTABLE DRUGS

Gemma Wood explores connected device development trends, the patient-centric benefits the technology has to offer and how, with the help of experienced manufacturing partners connected to key enabling technology partners, they can develop products that deliver improved patient outcomes.

A GAME CHANGER FOR HIGH-RISK MEDICATIONS VIA AN INTRANASAL DELIVERY PLATFORM

A GAME CHANGER FOR HIGH-RISK MEDICATIONS VIA AN INTRANASAL DELIVERY PLATFORM

Marcel Botha, Andreas Bilstein, Houssam Elghobary and Rouven Kraus discuss the benefits of the Validose digital health platform for the safe delivery of high-value and/or high-risk products.

THE SMART INHALER REVOLUTION: ARE WE THERE YET?

Cambridge Design Partnership

THE SMART INHALER REVOLUTION: ARE WE THERE YET?

Mark Allen, David Blakey and Karla Sanchez discuss the benefits of smart inhalers and how they could influence the commercialisation of respiratory drugs in the future.

HOW DIGITAL UX IN CLINICAL TRIALS CAN IMPROVE MEASURES

HOW DIGITAL UX IN CLINICAL TRIALS CAN IMPROVE MEASURES

Ben Cox discusses the key challenges, principles and advantages of following a user-experience approach to digital health technologies in clinical trials.

HOW RECENT NFC ADVANCES ENABLE ANTI-COUNTERFEIT DRUG CONTAINMENT & SUPPORT ADHERENCE

HOW RECENT NFC ADVANCES ENABLE ANTI-COUNTERFEIT DRUG CONTAINMENT & SUPPORT ADHERENCE

Sylvia Kaiser-Kershaw discusses how recent near-field communication tagging advancements can enable pharmaceutical companies to protect the authenticity and integrity of their products, while also making it easier for healthcare professionals and patients to use medications more effectively through intelligent drug delivery systems.

NO TYPE: AN APP TO PREDICT PATIENTS’ LIKELIHOOD TO TAKE MEDICATION AS PRESCRIBED

NO TYPE: AN APP TO PREDICT PATIENTS’ LIKELIHOOD TO TAKE MEDICATION AS PRESCRIBED

Louisa Harvey, Alper Hulusi, Bjarki Holm and Stefan Olafsson introduce their quick and accessible app for identifying whether or not a patient is likely to take their medication as prescribed.

CYBERSECURITY AND THE CHALLENGES OF CLOUD CONNECTIVITY

Gabrielle Whitworth-Smith

CYBERSECURITY AND THE CHALLENGES OF CLOUD CONNECTIVITY

Gabrielle Whitworth-Smith and Thomas Watts look at the benefits and risks associated with cloud connectivity and the accompanying cybersecurity challenges.

CONNECTIVITY IN HEALTHCARE – FROM THE MILLENNIUM TO THE PANDEMIC AND BEYOND

Napoleon Monroe

CONNECTIVITY IN HEALTHCARE – FROM THE MILLENNIUM TO THE PANDEMIC AND BEYOND

Napoleon Monroe looks back at the factors that influenced the underwhelming uptake of connectivity-enabling technologies in the healthcare sector over the first two decades of the 21st century, how the covid-19 pandemic changed everything and what current healthcare challenges connectivity might solve.

SUPPORTING PATIENTS ON THE ROAD TO SELF-CARE

SUPPORTING PATIENTS ON THE ROAD TO SELF-CARE

Michael Earl discusses the importance of transitioning current healthcare models to embrace patient self-management and how advanced drug delivery device technologies, such as connectivity, can ease this burden on overstretched healthcare services.

SMART DRUG DELIVERY DEVICES IMPROVE MEDICATION ADHERENCE: HERE’S HOW

SMART DRUG DELIVERY DEVICES IMPROVE MEDICATION ADHERENCE: HERE’S HOW

Paul Edalat and Mehdi Hatamian take an in-depth look at medication non-adherence and how technology can be used to improve compliance rates and optimise patient outcomes.

PUTTING PROCESS ENGINEERING INTO ACTION

Jonathan Kearns

PUTTING PROCESS ENGINEERING INTO ACTION

Jonathan Kearns and Kevin Huang consider how engineering competencies are being driven to the next level by leveraging process engineering and how this can transform drug-device projects.

PREMIUMCOAT<sup>®</sup> SOLUTIONS: HELPING CONTROL THE LEVEL OF SILICONE TO PROTECT SENSITIVE THERAPEUTICS

PREFILLED SYRINGES

Sebastien Cordier

PREMIUMCOAT^® SOLUTIONS: HELPING CONTROL THE LEVEL OF SILICONE TO PROTECT SENSITIVE THERAPEUTICS

Sébastien Cordier, Vincent Holterboch and Estelle Verger discuss how coated elastomer components, such as Aptar Pharma’s PremiumCoat^®, can help drug developers optimise the balance between component processability and minimising silicone migration into a drug product.

INJECTING THE FUTURE

INJECTING THE FUTURE

Simone Farina discusses Flex’s new smart autoinjector platform for the healthcare market, designed to enable original equipment manufacturers to accelerate time-to-market, reduce costs and boost reliability, while ensuring patient compliance.

CONNECTED DRUG DELIVERY – MAXIMISING ACCESS BY DESIGN

Jabil Healthcare

CONNECTED DRUG DELIVERY – MAXIMISING ACCESS BY DESIGN

Oliver Eden discusses the factors that drive the design and development of a reusable autoinjector solution. Foremost amongst these considerations is the patient, in terms of ease of use with the device itself and maximising access to the broadest possible population with a versatile, portfolio-enabling platform ready for the connected world.

ADVANCEMENTS AND EVOLUTION OF POWER SOURCES IN DRUG DELIVERY

ADVANCEMENTS AND EVOLUTION OF POWER SOURCES IN DRUG DELIVERY

William Welch considers the evolution of compressed gas alternatives to spring power for single-use drug delivery devices.

A CHECKLIST FOR AUTOINJECTOR DESIGN

A CHECKLIST FOR AUTOINJECTOR DESIGN

Michael Earl outlines the five key questions autoinjector designers typically ask during the development process and the choices available for tailoring autoinjector products.

EXCELLENCE THROUGH SIMPLICITY: PICCOJECT™ AUTOINJECTOR PLATFORM

Dr Fred Metzmann

EXCELLENCE THROUGH SIMPLICITY: PICCOJECT™ AUTOINJECTOR PLATFORM

Fred Metzmann and Chris Muenzer discuss the simplicity of the PiccoJect™ autoinjector platform and the company's commitment to sustainability.

Technology Showcase: CCBio’s Felice Dose

Technology Showcase: CCBio’s Felice Dose

CCBio introduces its wearable (on-body) injector, Felice Dose, which is capable of handling various drug volumes, concentrations and viscosities, as well as different injection speeds and delivery times.

OXYCAPT™: A SUPERIOR PRIMARY CONTAINER MATERIAL FOR BIOLOGICS AND GENE AND CELL THERAPIES

PREFILLED SYRINGES

Hiroki Hasegawa

Mitsubishi Gas Chemical

OXYCAPT™: A SUPERIOR PRIMARY CONTAINER MATERIAL FOR BIOLOGICS AND GENE AND CELL THERAPIES

Hiroki Hasegawa and Tomohiro Suzuki provide an overview of the OXYCAPT multilayer vial and syringe, along with a discussion of how OXYCAPT fares at low and very low temperatures.

XERIJECT™: NON-AQUEOUS FORMULATIONS FOR SC INJECTION OF ULTRA-HIGH-CONCENTRATION BIOLOGICS

Dr Steven Prestrelski

Xeris Pharmaceuticals

XERIJECT™: NON-AQUEOUS FORMULATIONS FOR SC INJECTION OF ULTRA-HIGH-CONCENTRATION BIOLOGICS

Steven Prestrelski introduces the XeriJect non-aqueous formulation technology that creates formulations with visco-elastic properties, opening the door to subcutaneous injection of difficult-to-formulate biologics, such as monoclonal antibodies, at very high concentrations.

1
2
3
…
31
Next

See what ondrugdelivery's readers and contributors think

Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.

Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.

Matt Kempton
Snr Project Engineer
Corning Incorporated

I am extremely impressed with the comprehensive presentation of information and problem/solution points detailed ... Kudos to you for an extremely well written article with succinct and robust scientific body of knowledge.

Donna Bibber
President
Micro Engineering Solutions

I picked up your latest copy at the Boston PODD event and read it with great interest. You’ve really come a long way and you put out an amazingly professional and value-packed magazine.

Top